630 Angiotensin Converting Enzyme (ACE)-inhibitor inhibits tumour growth and metastases formation in the Lewis lung carcinoma

H.Lindberg; J.Eriksen; P.Kristjansen; T.Skovsgaard; D.Nielsen

首页> 外文期刊>European Journal of Cancer Supplements >630 Angiotensin Converting Enzyme (ACE)-inhibitor inhibits tumour growth and metastases formation in the Lewis lung carcinoma

【24h】

630 Angiotensin Converting Enzyme (ACE)-inhibitor inhibits tumour growth and metastases formation in the Lewis lung carcinoma

机译：630血管紧张素转换酶（ACE）抑制剂可抑制路易斯肺癌中的肿瘤生长和转移灶的形成

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2003年第5期|共2页
作者
H.Lindberg; J.Eriksen; P.Kristjansen; T.Skovsgaard; D.Nielsen;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 630 Angiotensin Converting Enzyme (ACE)-inhibitor inhibits tumour growth and metastases formation in the Lewis lung carcinoma [J] . H.Lindberg, J.Eriksen, P.Kristjansen, European Journal of Cancer Supplements . 2003,第5期

机译：630血管紧张素转换酶（ACE）抑制剂可抑制路易斯肺癌中的肿瘤生长和转移灶的形成
2. Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta (TGF-beta) and alpha-actomyosin (alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis. [J] . Molteni A, Wolfe LF, Ward WF, Current pharmaceutical design . 2007,第13期

机译：血管紧张素II受体阻滞剂和两种血管紧张素转化酶抑制剂对转化生长因子-β（TGF-beta）和α-肌动球蛋白（alpha SMA）的影响，它们是放射性诱导的肺病和肺纤维化的重要介质。
3. Effect of an Angiotensin II Receptor Blocker and Two Angiotensin Converting Enzyme Inhibitors on Transforming Growth Factor-β (TGF-β) and α-Actomyosin (α SMA), Important Mediators of Radiation-Induced Pneumopathy and Lung Fibrosis [J] . Agostino Molteni Lisa F. Wolfe William F. Ward C. Hsin Tsao Loredana Brizio Molteni Patricia Veno Brian L. Fish Joan M. Taylor Norma Quintanilla Betty Herndon John E. Moulder Current Pharmaceutical Design . 2007,第13期

机译：血管紧张素II受体阻滞剂和两种血管紧张素转化酶抑制剂对放射性诱导的肺病和肺纤维化的重要调节剂转化生长因子-β（TGF-β）和α-肌动球蛋白（αSMA）的影响
4. Synthesis of the first highly potent inhibitor of the three vasopeptidases:endothelin converting enzyme (ECE),angiotensin converting enzyme (ACE) and neprilysin (NEP) [C] . Nicolas Inguimbert, Herve Poras, Pascale Coric, European Peptide Symposium . 2002

机译：三种血管肽酶的第一高效抑制剂的合成：内皮素转化酶（ECE），血管紧张素转化酶（ACE）和Neplysin（NEP）
5. PHOSPHONAMIDATE PEPTIDE ANALOGUES AS INHIBITORS OF ENKEPHALINASE AND ANGIOTENSIN-CONVERTING ENZYME (TRANSITION-STATE INHIBITORS, METALLOENDOPEPTIDASE). [D] . ELLIOTT, RICHARD LOUIS. 1984

机译：膦酰胺肽类似物作为脑啡肽酶和血管紧张素转化酶的抑制剂（过渡态抑制剂，金属内肽酶）。
6. Human Tissue Angiotensin Converting Enzyme (ACE) Activity Is Regulated by Genetic Polymorphisms Posttranslational Modifications Endogenous Inhibitors and Secretion in the Serum Lungs and Heart [O] . Viktor Bánhegyi, Attila Enyedi, Gábor Áron Fülöp, 2021

机译：人体组织血管紧张素转化酶（ACE）活性由血清肺和心脏在血清肺和心脏中的遗传多态性后期修饰内源性抑制剂和分泌中调节
7. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities [O] . Koji Yanase, Hitoshi Yoshiji, Yasuhide Ikenaka, 2007

机译：通过抗血管生成活性组合5-氟尿嘧啶和血管紧张素转化酶抑制剂的组合抑制肝细胞癌生长和肝癌发生的协同抑制作用
8. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEls) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension. Comparative Effectiveness Review, Number 10 [R] . Matchar, D. B., McCrory, D. C., Orlando, L. A., 2007

机译：血管紧张素转换酶抑制剂（aCEls）和血管紧张素II受体拮抗剂（aRBs）治疗原发性高血压的疗效比较。比较效力评估，第10号

630 Angiotensin Converting Enzyme (ACE)-inhibitor inhibits tumour growth and metastases formation in the Lewis lung carcinoma

著录项

相似文献

相关主题

期刊订阅